Oral Corticosteroid Relieves Post-COVID-19 Anosmia in a 35-Year-Old Patient
Coronavirus disease 2019 (COVID-19) is a highly infectious respiratory illness caused by SARS-CoV-2. Not much is yet known about this new viral disease. In our early encounter with the COVID-19, before the pandemic and during the early days of dealing with this novel viral disease in our country, we...
Saved in:
Main Authors: | Sam K. Touisserkani, Azin Ayatollahi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Case Reports in Otolaryngology |
Online Access: | http://dx.doi.org/10.1155/2020/5892047 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Early recovery following new onset anosmia during the COVID-19 pandemic – an observational cohort study
by: Claire Hopkins, et al.
Published: (2020-05-01) -
An Extremely Rare Cause of Isolated Congenital Anosmia
by: Chia Saw, et al.
Published: (2022-01-01) -
Anosmia, dysgeusia and malnutrition in chronic kidney disease: A systematic review
by: Gaetano Ferrara, et al.
Published: (2025-02-01) -
Corticosteroid Pulses for Hospitalized Patients with COVID-19: Effects on Mortality
by: Ivan Cusacovich, et al.
Published: (2021-01-01) -
Extracellular matrix turnover in severe COVID-19 is reduced by corticosteroids
by: Janesh Pillay, et al.
Published: (2025-01-01)